PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, has announced the expansion of its bottling line capacity at its Commercial […]
Advarra has introduced a new platform called SiteIQ to expedite clinical trial start-up by facilitating protocol planning and site selection processes. The platform leverages Advarra’s data resources and expertise to offer insights regarding clinical research […]
CyanVac LLC and its subsidiary, Blue Lake Biotechnology, Inc., clinical-stage biopharmaceutical companies developing vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector, today announced the enrollment of the first participant in a Phase 1 […]
German generic drug manufacturer STADA Group has agreed to acquire a portfolio of well-established consumer healthcare brands from biopharmaceutical firm Sanofi to expand its European Consumer Healthcare portfolio. German generic drug manufacturer STADA Group has […]
The FDA cleared Tecartus for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), adding to the drug’s existing indication for previously treated mantle cell lymphoma. Friday’s go-ahead sets off a small […]